OHSU in the news

Obstetrics in the Time of Dobbs

Medscape July 17, 2025
An article by Medscape about obstetrics care post-Dobbs highlights the Ryan Program and the Complex Family Planning Visiting Resident Elective at OHSU. Alyssa Colwill, M.D., says, “We’ve seen in states like Idaho a large exodus of Ob/Gyns practicing in that state. And since the Dobbs decision, they have closed two labor and delivery units in the state.”

Adults largely don't need tetanus, diphtheria vaccine boosters, researchers say

Center for Infectious Disease Research and Policy July 16, 2025
Continued coverage from an OHSU News story on a review by Mark Slifka, Ph.D., that shows the U.S. could safely drop tetanus and diphtheria booster shots for adults, “The review’s findings underscore the remarkable‍ durability of protection conferred by childhood vaccination schedules against tetanus and diphtheria. These diseases were once a significant public health threat, with devastating ‌mortality rates.”

American Adults Could Forgo Tetanus and Diphtheria Boosters, OHSU Scientist Says

Willamette Week July 16, 2025
Continued coverage from an OHSU News story on a review by Mark Slifka, Ph.D., that shows the U.S. could safely drop tetanus and diphtheria booster shots for adults, “The review’s findings underscore the remarkable‍ durability of protection conferred by childhood vaccination schedules against tetanus and diphtheria. These diseases were once a significant public health threat, with devastating ‌mortality rates.”

Scientists develop tool that improves tissue cancer analysis

Medical Xpress July 16, 2025
OHSU researchers develop a powerful new tool, dubbed OmicsTweezer, that makes it easier to study the mix of cell types in human tissue, which is crucial for understanding diseases such as cancer. Zheng Xia, Ph.D., says, “The tumor microenvironment, made up of diverse cell types that shape tumor development and patient outcomes, has been a longstanding research priority at the Knight Cancer Institute.”

Removal of boxed warning clears testosterone of heart-related risk, but concerns remain

Healio Endocrine Today July 15, 2025
A story in Healio on results from a randomized controlled trial that led the FDA to make a major change to testosterone replacement therapy labeling quotes Eric Orwoll, M.D., “At least over a two-year treatment period, testosterone replacement therapy appeared to impart no additional risk of major adverse cardiac events.”

Portland named among ‘cities on the rise’ as Oregon falls in state business rankings

KOIN-TV July 15, 2025
An article in Medscape documents a study by Amnon Sonnenberg, M.D., that revealed subtypes of gastroesophageal reflux disease, or GERD, such as erosive esophagitis, nonerosive reflux disease and Barrett esophagus were associated with an increased risk for colonic neoplasia in older adults, with the risk more pronounced for colon polyps than for colorectal cancer.

How Sarah Harris found power in her eczema story

The Educated Patient July 15, 2025
In an interview in The Educated Patient, a patient recounts her experience in treating eczema, including a childhood visit to OHSU Hospital and consultation with Jon Hanifin, M.D.

Study Suggests Dropping Tetanus and Diphtheria Boosters

Life Technology July 15, 2025
The U.S. could safely drop tetanus and diphtheria booster shots for adults and save an estimated $1 billion a year, according to a new review led by OHSU. Mark Slifka, Ph.D., says, “By maintaining high childhood vaccination coverage, we not only protect kids, but we may actually be able to reduce adult booster vaccinations.”
See more stories